세계의 팁소보(Tibsovo) 시장 보고서(2025년)

Tibsovo Global Market Report 2025

US $ 4,490 ￦ 6,482,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,370,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 12,257,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계의 팁소보 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 예측기간 중에 예상되는 주요 동향으로는 정밀종양학의 혁신, 전략적 제휴와 파트너십의 확대, 저분자 의약품의 혁신 진전, 규제당국의 허가, 치료 프로토콜의 진화 등이 있습니다.

급성 골수성 백혈병의 유병률 증가는 앞으로 팁소보 시장의 성장을 가속할 것으로 예측됩니다. 이 유형의 백혈병을 발병하기 쉬운 연령층에 이르는 사람이 증가하고 있습니다. 예방, 질병의 진행을 억제하고, 치료 반응을 개선하고, 생존 성적을 향상시킴으로써, AML에 대처합니다. 예를 들어 2023년 2월, Leukemia Foundation은 2022년부터 2035년까지 7,000명 이상의 소아, 6,000명 이상의 젊은 성인, 10만 8,000명 이상의 성인(25-65세)이, 주로 ALL, AML, 비호지킨 림프종을 포함한 혈액암으로 진단된다고 보고했습니다.

팁소보 시장에서 사업을 전개하는 주요 기업은 약제의 리치를 넓히고 IDH1 변이암에서의 리더십을 유지하기 위해 규제 당국의 승인 취득에 주력하고 있습니다. 예를 들어, 2023년 10월, 프랑스 제약회사 Servier Laboratoires는 유럽 위원회로부터 팁소보(이보시데닙 정제)의 승인을 취득하고, 치료가 곤란한 2종의 암종에 대한 유럽 최초로 유일한 IDH1 표적 치료제으로서 허가되었습니다. R132 돌연변이를 갖는 신규 진단 AML 환자에 대한 아자시티딘과의 병용 요법, 적어도 1회의 전신 요법 경력이 있는 동변이를 갖는 국소 진행성 또는 전이성 담관암을 가진 성인 환자에 대한 단일 요법으로 허가되었습니다. 희귀 질병 의약품의 지정을 받은 이번 승인은 중요한 미충족 의료 요구를 충족하는 것으로, 이러한 환자의 결과와 QOL 개선에 새로운 희망을 가져다줍니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계의 팁소보 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업의 분석
• 세계의 팁소보 시장 : 성장률 분석
• 세계의 팁소보 시장 실적 : 규모와 성장, 2019-2024년
• 세계의 팁소보 시장 예측 : 규모와 성장, 2024-2029년, 2034F
• 세계의 팁소보 시장 : 총 잠재 시장 규모(TAM)

제6장 시장 세분화

• 세계의 팁소보 시장 : 제품별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
• 정제
• 캡슐
• 병용 요법
• 주사제
• 세계의 팁소보 시장 : 투여 방법별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
• 경구 투여
• 정맥내 투여
• 세계의 팁소보 시장 : 유통 채널별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
• 병원 약국
• 소매 약국
• 온라인 약국
• 세계의 팁소보 시장 : 용도별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
• 암 치료
• 급성 골수성 백혈병
• 화학요법
• 표적요법
• 세계의 팁소보 시장 : 최종 사용자별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
• 병원
• 전문 클리닉
• 연구기관
• 재택 케어 설정
• 세계의 팁소보 시장 : 정제, 유형별 세분화 : 분석과 예측, 2019-2024년, 2024-2029F, 2034F
• 경구정
• 서방정
• 세계의 팁소보 시장 : 캡슐, 유형별 세분화 : 분석과 예측, 2019-2024년, 2024-2029F, 2034F
• 소프트젤 캡슐
• 하드젤 캡슐
• 세계의 팁소보 시장 : 병용 요법, 유형별 세분화 : 분석과 예측, 2019-2024년, 2024-2029F, 2034F
• 팁소보 화학요법제
• 팁소보 표적 치료제
• 세계의 팁소보 시장 : 주사제, 유형별 세분화 : 분석과 예측, 2019-2024년, 2024-2029F, 2034F
• 정맥 주사
• 피하 주사

제7장 지역별/국가별 분석

• 세계의 팁소보 시장 : 지역별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
• 세계의 팁소보 시장 : 국가별 분석과 예측, 2019-2024년, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

• 팁소보 시장 : 경쟁 구도
• 팁소보 시장 : 기업 프로파일
  • Servier Laboratoires : 개요, 제품 및 서비스, 전략 및 재무 분석
  • Agios Pharmaceuticals : 개요, 제품 및 서비스, 전략 및 재무 분석

제31장 세계 시장 경쟁 벤치마킹과 대시보드

제32장 주요 인수합병(M&A)

제33장 최근 시장 동향

제34장 시장의 잠재력이 높은 국가, 부문, 전략

• 팁소보 시장(2029년) : 새로운 기회를 제공하는 국가
• 팁소보 시장(2029년) : 새로운 기회를 제공하는 부문
• 팁소보 시장(2029년) : 성장 전략
  • 시장 동향에 기초한 전략
  • 경쟁 전략

제35장 부록

JHS

영문 목차

영문목차

Tibsovo is an oral targeted therapy mainly prescribed for adults diagnosed with acute myeloid leukemia (AML) or cholangiocarcinoma that exhibit a specific mutation in the IDH1 gene. By targeting and inhibiting the mutated IDH1 enzyme, Tibsovo lowers the production of an abnormal metabolite that facilitates cancer cell proliferation, thereby aiding in the restoration of normal cell differentiation and decelerating disease advancement.

Tibsovo is available in various forms including tablets, capsules, combination therapies, and injectable options. The tablet form, which contains ivosidenib, is a convenient oral solid dosage designed for once-daily use. The drug can be administered both orally and intravenously and is distributed through hospital pharmacies, retail outlets, and online platforms. It serves several applications such as cancer therapy, AML treatment, chemotherapy, and precision-targeted therapies. These products are utilized by a range of end users including hospitals, specialized clinics, research centers, and homecare environments.

The tibsovo market research report is one of a series of new reports from The Business Research Company that provides tibsovo market statistics, including tibsovo industry global market size, regional shares, competitors with a tibsovo market share, detailed tibsovo market segments, market trends and opportunities, and any further data you may need to thrive in the tibsovo industry. This tibsovo market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tibsovo market size has grown strongly in recent years. It will grow from $0.99 billion in 2024 to $1.08 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. Growth in the historical period has been driven by the rising incidence of AML, increased identification of IDH1 mutations among cancer patients, enhanced awareness around targeted treatments, and a surge in oncology-focused research and development.

The tibsovo market size is expected to see strong growth in the next few years. It will grow to $1.55 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. This anticipated expansion is due to the rising preference for targeted cancer medications, broader use of IDH1 inhibitors, heightened investment in biopharmaceutical R&D, and favorable regulatory pathways. Key trends anticipated during the forecast period include growth in precision oncology innovations, strategic alliances and partnerships, progress in small-molecule drug innovations, regulatory green lights, and evolution in therapeutic protocols.

The increasing prevalence of acute myeloid leukemia is expected to propel the growth of the Tibsovo market going forward. Acute myeloid leukemia (AML) is an aggressively progressing cancer of the blood and bone marrow that directly impacts blood cell production, immune function, and overall physical health. This rise in prevalence is largely attributed to the global increase in the aging population, as AML primarily affects older adults. With longer life expectancy, more individuals are reaching the age group most vulnerable to developing this type of leukemia. Tibsovo addresses AML by targeting IDH1-mutated cancer cells to inhibit abnormal cell growth, reduce disease progression, improve treatment response, and enhance survival outcomes by restoring normal blood cell production. For example, in February 2023, the Leukemia Foundation, an Australia-based non-profit organization, reported that between 2022 and 2035, over 7,000 children, 6,000 young adults, and 108,000 adults (aged 25-65) are expected to be diagnosed with blood cancers, primarily including ALL, AML, and non-Hodgkin lymphoma. As a result, the rising prevalence of acute myeloid leukemia is fueling the growth of the Tibsovo market.

Major companies operating in the Tibsovo market are focusing on obtaining regulatory approvals to broaden the drug's reach and sustain leadership in IDH1-mutated cancers. Regulatory approvals refer to the official permissions granted by health authorities that enable a drug to be legally marketed and used for designated medical conditions after its safety and effectiveness are confirmed. For instance, in October 2023, Servier Laboratoires, a France-based pharmaceutical company, received approval from the European Commission for Tibsovo (ivosidenib tablets), making it the first and only IDH1-targeted therapy authorized in Europe for two difficult-to-treat cancer types. The drug is approved for use in combination with azacitidine for newly diagnosed AML patients with an IDH1 R132 mutation who are ineligible for standard induction chemotherapy, and as a monotherapy for adults with locally advanced or metastatic cholangiocarcinoma harboring the same mutation after at least one prior systemic treatment. This approval, which benefits from orphan drug designation, fulfills critical unmet medical needs and offers new hope for improved outcomes and quality of life for these patients.

In December 2023, Servier Group, a France-based pharmaceutical company offering Tibsovo (ivosidenib tablets) as a targeted therapy for patients with IDH1-mutated cancers, acquired exclusive rights to develop, manufacture, and commercialize Tibsovo from CStone Pharmaceuticals for $44 million. This strategic acquisition aims to expand Servier Group's presence in the rapidly growing China and Singapore markets by securing exclusive rights to Tibsovo. It also strengthens the company's oncology portfolio with a targeted therapy for IDH1-mutated cancers and accelerates patient access to this innovative treatment in these key regions. CStone Pharmaceuticals is a China-based biopharmaceutical company that specializes in oncology treatments.

Major players in the tibsovo market are Servier Laboratoires, and Agios Pharmaceuticals.

North America was the largest region in the tibsovo market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in tibsovo report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the tibsovo market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tibsovo market consists of sales of products including oral tablets, extended-release tablets, soft gel capsules, intravenous injection, and subcutaneous injection. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tibsovo Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tibsovo market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tibsovo ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tibsovo market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Tablets; Capsules; Combination Therapy; Injectable Forms
• 2) By Drug Administration: Oral Administration; Intravenous Administration
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• 4) By Application: Cancer Treatment; Acute Myeloid Leukemia; Chemotherapy; Targeted Therapy
• 5) By End User: Hospitals; Specialty Clinics; Research Institutions; Homecare Settings
• Subsegments:

1) By Tablets; Oral Tablets; Extended-Release Tablets

2) By Capsules; Soft Gel Capsules; Hard Gel Capsules

3) By Combination Therapy; Tibsovo + Chemotherapy Agents; Tibsovo + Targeted Therapy Agents

4) By Injectable Forms; Intravenous Injection; Subcutaneous Injection

• Companies Mentioned: Servier Laboratoires; Agios Pharmaceuticals;
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tibsovo Market Characteristics

3. Tibsovo Market Trends And Strategies

4. Tibsovo Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Tibsovo Growth Analysis And Strategic Analysis Framework

• 5.1. Global Tibsovo PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Tibsovo Market Growth Rate Analysis
• 5.4. Global Tibsovo Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Tibsovo Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Tibsovo Total Addressable Market (TAM)

6. Tibsovo Market Segmentation

• 6.1. Global Tibsovo Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablets
• Capsules
• Combination Therapy
• Injectable Forms
• 6.2. Global Tibsovo Market, Segmentation By Drug Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Administration
• Intravenous Administration
• 6.3. Global Tibsovo Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.4. Global Tibsovo Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cancer Treatment
• Acute Myeloid Leukemia
• Chemotherapy
• Targeted Therapy
• 6.5. Global Tibsovo Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Research Institutions
• Homecare Settings
• 6.6. Global Tibsovo Market, Sub-Segmentation Of Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Tablets
• Extended-Release Tablets
• 6.7. Global Tibsovo Market, Sub-Segmentation Of Capsules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Soft Gel Capsules
• Hard Gel Capsules
• 6.8. Global Tibsovo Market, Sub-Segmentation Of Combination Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tibsovo + Chemotherapy Agents
• Tibsovo + Targeted Therapy Agents
• 6.9. Global Tibsovo Market, Sub-Segmentation Of Injectable Forms, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intravenous Injection
• Subcutaneous Injection

7. Tibsovo Market Regional And Country Analysis

• 7.1. Global Tibsovo Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Tibsovo Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tibsovo Market

• 8.1. Asia-Pacific Tibsovo Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Tibsovo Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Tibsovo Market, Segmentation By Drug Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Tibsovo Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tibsovo Market

• 9.1. China Tibsovo Market Overview
• 9.2. China Tibsovo Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Tibsovo Market, Segmentation By Drug Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Tibsovo Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tibsovo Market

• 10.1. India Tibsovo Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Tibsovo Market, Segmentation By Drug Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Tibsovo Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tibsovo Market

• 11.1. Japan Tibsovo Market Overview
• 11.2. Japan Tibsovo Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Tibsovo Market, Segmentation By Drug Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Tibsovo Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tibsovo Market

• 12.1. Australia Tibsovo Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Tibsovo Market, Segmentation By Drug Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Tibsovo Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tibsovo Market

• 13.1. Indonesia Tibsovo Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Tibsovo Market, Segmentation By Drug Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Tibsovo Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tibsovo Market

• 14.1. South Korea Tibsovo Market Overview
• 14.2. South Korea Tibsovo Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Tibsovo Market, Segmentation By Drug Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Tibsovo Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tibsovo Market

• 15.1. Western Europe Tibsovo Market Overview
• 15.2. Western Europe Tibsovo Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Tibsovo Market, Segmentation By Drug Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Tibsovo Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tibsovo Market

• 16.1. UK Tibsovo Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Tibsovo Market, Segmentation By Drug Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Tibsovo Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tibsovo Market

• 17.1. Germany Tibsovo Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Tibsovo Market, Segmentation By Drug Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Tibsovo Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tibsovo Market

• 18.1. France Tibsovo Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Tibsovo Market, Segmentation By Drug Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Tibsovo Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tibsovo Market

• 19.1. Italy Tibsovo Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Tibsovo Market, Segmentation By Drug Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Tibsovo Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tibsovo Market

• 20.1. Spain Tibsovo Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Tibsovo Market, Segmentation By Drug Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Tibsovo Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tibsovo Market

• 21.1. Eastern Europe Tibsovo Market Overview
• 21.2. Eastern Europe Tibsovo Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Tibsovo Market, Segmentation By Drug Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Tibsovo Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tibsovo Market

• 22.1. Russia Tibsovo Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Tibsovo Market, Segmentation By Drug Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Tibsovo Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tibsovo Market

• 23.1. North America Tibsovo Market Overview
• 23.2. North America Tibsovo Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Tibsovo Market, Segmentation By Drug Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Tibsovo Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tibsovo Market

• 24.1. USA Tibsovo Market Overview
• 24.2. USA Tibsovo Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Tibsovo Market, Segmentation By Drug Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Tibsovo Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tibsovo Market

• 25.1. Canada Tibsovo Market Overview
• 25.2. Canada Tibsovo Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Tibsovo Market, Segmentation By Drug Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Tibsovo Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tibsovo Market

• 26.1. South America Tibsovo Market Overview
• 26.2. South America Tibsovo Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Tibsovo Market, Segmentation By Drug Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Tibsovo Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tibsovo Market

• 27.1. Brazil Tibsovo Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Tibsovo Market, Segmentation By Drug Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Tibsovo Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tibsovo Market

• 28.1. Middle East Tibsovo Market Overview
• 28.2. Middle East Tibsovo Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Tibsovo Market, Segmentation By Drug Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Tibsovo Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tibsovo Market

• 29.1. Africa Tibsovo Market Overview
• 29.2. Africa Tibsovo Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Tibsovo Market, Segmentation By Drug Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Tibsovo Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tibsovo Market Competitive Landscape And Company Profiles

• 30.1. Tibsovo Market Competitive Landscape
• 30.2. Tibsovo Market Company Profiles
  • 30.2.1. Servier Laboratoires Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Agios Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis

31. Global Tibsovo Market Competitive Benchmarking And Dashboard

32. Key Mergers And Acquisitions In The Tibsovo Market

33. Recent Developments In The Tibsovo Market

34. Tibsovo Market High Potential Countries, Segments and Strategies

• 34.1 Tibsovo Market In 2029 - Countries Offering Most New Opportunities
• 34.2 Tibsovo Market In 2029 - Segments Offering Most New Opportunities
• 34.3 Tibsovo Market In 2029 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer

관련자료